{"nct_id":"NCT00320385","title":"Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2015-04","start_date":"2005-11","start_date_type":null,"primary_completion_date":"2007-06","primary_completion_date_type":"ACTUAL","completion_date":"2010-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}